Metabolic gene polymorphisms and p53 mutations in healthy centenarians and younger controls

Biomarkers

Volumn 8, Issue 6, 2003, Pages 522-528

  Gaspari, L ^a   Pedotti, P ^a   Bonafe M ^b   Franceschi, C ^b   Marinelli, D ^a   Mari, D ^c   Garte, S ^d   Taioli, Emanuela ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d Genetics Research Institute   (Italy)

Author keywords

Ageing; Chronic diseases; Molecular epidemiology

Indexed keywords

CARCINOGEN; GENE PRODUCT; PROTEIN P53;

ADULT; AGED; AGING; ARTICLE; BIOACCUMULATION; CANCER RISK; CELL AGING; CELL DEATH; CHRONIC DISEASE; CLINICAL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; ENVIRONMENTAL EXPOSURE; ETHNIC GROUP; FEMALE; GENE DELETION; GENE FREQUENCY; GENE MUTATION; GENETIC TRAIT; GENOTYPE; GERM LINE; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; HUMAN EXPERIMENT; ITALY; LONGEVITY; MALE; NORMAL HUMAN; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; AGING; CASE-CONTROL STUDIES; EPIDEMIOLOGY, MOLECULAR; FEMALE; GLUTATHIONE TRANSFERASE; HUMANS; ITALY; LONGEVITY; MALE; METABOLISM; MUTATION; POLYMORPHISM, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 1842588641     PISSN: 1354750X     EISSN: None     Source Type: Journal    
DOI: 10.1080/13547500310001627519     Document Type: Article

References (27)

1. Birgander, R., Själander, A., Rannug, A., Alexandrie, A. K. O., Ingelman Sundberg, M., Seidegard, J., Tornling, G., Beckman, G. and Beckman, L. 1995, p53 polymorphisms and haplotypes in lung cancer. Carcinogenesis, 16, 2233-2236.
2. Biro, E., Kalina, I., Salagovic, J., Habalova, V., Hrivak, M. and Valansky, L. 2000, p53 single nucleotide polymorphisms and bladder cancer. Neoplasma, 47, 303-306.
3. Biros, E., Kalina, I., Kohut, A., Stubna, J. and Salagovic, J. 2001, Germ line polymorphisms of the tumor suppressor gene p53 and lung cancer. Lung Cancer, 31, 157-162.
4. Bonafè, M., Olivieri, F., Mariv, D., Baggio, G., Mattace, R., Sansoni, P., De Benedictis, G., De Luca, M., Bertolini, S., Barbi, C., Monti, D. and Franceschi, C. 1999, p53 variants predisposing to cancer are present in healthy centenarians. American Journal of Human Genetics, 64, 292-295.
5. D'Errico, A., Malats, N., Vineis, P. and Boffetta, P. 1999, Review of studies of selected metabolic polymorphisms and cancer. IARC Scientific Publications, 148, 323-393.
6. Franceschi, C., Motta, L., Valensin, S., Rapisarda, R., Franzone, A., Berardelli, M., Motta, M., Bonafè, M., Ferrucci, L., Deiana, L., Pes, G., Carru, C., Desole, S., Barbi, C., Gemelli, C., Lescai, F., Olivieri, F., Marchegiani, F., Cardelli, M., Cavallone, L., Gueresi, P., Cossarizza, A., Troiano, L., Pini, G., Sansoni, P., Passeri, G., Lisa, R., Spazzafumoo, L., Amadio, L., Giunta, S., Stecconi, R., Morresi, R., Viticchi, C., Mattace, R., De Benedictis, G., Baggio, G. and The Italian Multicenter Study on Centenarians (IMUSE). 2000, Do men and women follow different trajectories to reach longevity? Aging (Milano), 2, 77-84.
7. Garte, S., Ganguly, S. and Taioli, E. 2003, Effect of genotype on steady-state CYP1A1 gene expression in human peripheral lymphocytes. Biochemical Pharmacology, 65, 441-445.
8. Garte, S., Gaspari L., Alexandrie, A. K., Ambrosone, C., Autrup, H., Autrup, J. L., Baranova, H., Bathum, L., Benhamou, S., Boffetta, P., Bouchardy, C., Breskvar, K., Brockmoller, J., Cascorbi, I., Clapper, M. L., Coutelle, C., Daly, A., Dell'Omo, M., Dolzan, V., Dresler, C. M., Fryer, A., Haugen, A., Hein, D. W., Hildesheim, A., Hirvonen, A., Hsieh, L. L., Ingelman-Sundberg, M., Kalina, I., Kang, D., Kihara, M., Kiyohara, C., Kremers, P., Lazarus, P., Le Marchand, L., Lechner, M. C., van Lieshout, E. M., London, S., Manni, J. J., Maugard, C. M., Morita, S., Nazar-Stewart, V., Noda, K., Oda, Y., Parl, F. F., Pastorelli, R., Persson, I., Peters, W. H., Rannug, A., Rebbeck, T., Risch, A., Roelandt, L., Romkes, M., Ryberg, D., Salagovic, J., Schoket, B., Seidegard, J., Shields, P. G., Sim, E., Sinnet, D., Strange, R. C., Stucker, I., Sugimura, H., To-Figueras, J., Vineis, P., Yu, M. C. and Taioli, E. 2001, Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiology, Biomarkers and Prevention, 10, 1239-1248.
9. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C. C. 1991, p53 mutations in human cancers. Science, 253, 49-53.
10. Johnson, T. E. 1997, Genetic influences on aging. Experimental Gerontology, 32, 11-22.
11. Kinzler, K. W. and Vogelstein, B. 1997, Cancer-susceptibility genes. Gatekeepers and caretakers. Nature, 386, 761-763.
12. Law, J. C., Strong, L. C., Chidambaram, A. and Ferrell, R. E. 1991, Germ line mutation in exon 5 of the p53 gene in an extended cancer family. Cancer Research, 51, 6385-6387.
13. Lazar, V., Hazard, F., Bertin, F., Janin, N., Bellet, D. and Bressac, B. 1993, Simple sequence repeat polymorphism within the p53 gene. Oncogene, 8, 1703-1705.
14. Leroi, A. M., Koufopanou, V. and Burt, A. 2003, Cancer selection. Nature Reviews, Cancer, 3, 226-231.
15. Liu, G., Miller, D. P., Zhou, W., Thurston, S. W., Fan, R., Xu, L. L., Lynch, T. J., Wain, J. C., Su, L. and Christiani, D. 2001, Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma. Cancer Research, 61, 8718-8722.
16. McDaniel, T., Carbone, D., Takahashi, T., Chumakov, P., Chang, E. H., Pirollo, K. F., Yin, J., Huang, Y. and Meltzer, S. J. 1991, The Msp1 polymorphism in intron 6 of p53 (TP53) detected by digestion of PCR products. Nucleic Acids Research, 19, 4796.
17. Miller, D. P., Liu, G., De Vivo, I., Lynch, T. J., Wain, J. C., Su, L. and Christiani, D. 2002, Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. Cancer Research, 62, 2819-2823.
18. Roff, D. A. and Bentzen, P. 1989, The statistical analysis of mitochondrial DNA polymorphisms: chi square and the problem of small samples. Molecular Biology and Evolution, 6, 539-545.
19. Själander, A., Birgander, R., Kivelä, A. and Beckman, G. 1995, p53 polymorphisms and haplotypes in different ethnic groups. Human Heredity, 45, 144-149.
20. Själander, A., Birgander, R., Hallmans, G., Cajander, S., Lenner, P., Athlin, L., Beckman, G. and Beckman, L. 1996, p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis, 17, 1313-1316.
21. Taioli, E., Trachman, J., Chen, X., Toniolo, P. and Garte, S. J. 1995, A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African - American women. Cancer Research, 55, 3757-3758.
22. Taioli, E., Mari, D., Franceschi, C., Bonafè, M., Monti, D., Bertolini, S., Marinelli, D. and Garte, S. 2001, Polymorphisms of drug-metabolizing enzymes in healthy nonagenarians and centenarians: difference at GSTT1 locus. Biochemical and Biophysical Research Communications, 280, 1389-1392.
23. Thomas, M., Kalita, A., Labrecque, S., Pim, D., Banks, L. and Matlashewski, G. 1999, Two polymorphic variants of wild-type p53 differ biochemically and biologically. Molecular and Cellular Biology, 19, 1092-1100.
24. Vineis, P., Veglia, F., Benhamou, S., Butkiewicz, D., Cascorbi, I., Clapper, M. L., Dolzan, V., Haugen, A., Hirvonen, A., Ingelman-Sundberg, M., Kihara, M., Kiyohara, C., Kremers, P., Le Marchand, L., Ohshima, S., Pastorelli, R., Rannug, A., Romkes, M., Schoket, B., Shields, P., Strange, R. C., Stucker, I., Sugimura, H., Garte, S., Gaspari, L. and Taioli, E. 2003, CYP1A1 T3801 C polymorphism and lung cancer: a pooled analysis of 2451 cases and 3358 controls. International Journal of Cancer, 104, 650-657.
25. Wang-Gohrke, S., Weikel, W., Risch, H., Vesprini, D., Abrahamson, J., Lerman, C., Godwin, A., Moslehi, R., Olipade, O., Brunet, J. S., Stickeler, E., Kreienberg, R., Weber, B., Narod, S. A. and Runnebaum, I. B 1999, Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations. British Journal of Cancer, 81, 179-183.
26. Wang-Gohrke, S., Becher, H., Kreienberg, R., Runnebaum, I. B. and Chang-Cloude, J. 2002, Intron 3 16 bp duplication polymorphism of p53 is associated with an increase risk for breast cancer by the age of 50 years. Pharmacogenetics, 12, 269-272.
27. Wani, M. A., Zhu, Q., El-Mahdy, M., Venkatachalam, S. and Wani, A. A. 2000, Enhanced sensitivity to anti-benzo(a)pyrene-diol-epoxide DNA damage correlates with decreased global genomic repair attributable to abrogated p53 function in human cells. Cancer Research, 60, 2273-2280.